PMC:7195088 / 8077-8376 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"162","span":{"begin":291,"end":299},"obj":"Species"},{"id":"226","span":{"begin":113,"end":122},"obj":"Disease"},{"id":"227","span":{"begin":282,"end":290},"obj":"Disease"}],"attributes":[{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Tax:9606"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"MESH:D003643"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" (b) can be associated with a substantial risk of delaying appropriate treatment, thereby potentially increasing mortality. Because of the limited available data on both the microbiologic epidemiology (and the prevalence of antimicrobial resistance) of bacterial superinfections in COVID-19 patients"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T35","span":{"begin":282,"end":290},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" (b) can be associated with a substantial risk of delaying appropriate treatment, thereby potentially increasing mortality. Because of the limited available data on both the microbiologic epidemiology (and the prevalence of antimicrobial resistance) of bacterial superinfections in COVID-19 patients"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T27","span":{"begin":2,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T28","span":{"begin":28,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" (b) can be associated with a substantial risk of delaying appropriate treatment, thereby potentially increasing mortality. Because of the limited available data on both the microbiologic epidemiology (and the prevalence of antimicrobial resistance) of bacterial superinfections in COVID-19 patients"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T35","span":{"begin":224,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":" (b) can be associated with a substantial risk of delaying appropriate treatment, thereby potentially increasing mortality. Because of the limited available data on both the microbiologic epidemiology (and the prevalence of antimicrobial resistance) of bacterial superinfections in COVID-19 patients"}